Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary ...
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ...
Dear Dr. Roach: What is lupus, and what does it do to your body? I just had a friend diagnosed with it after many months of tests. — T.S.B. Dear T.S.B.: The term "lupus" generally means systemic lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results